Manufacturer:

Nabriva Therapeutics Us, Inc

Name:

XENLETA

Category:

J Code

HCPCS:

J0691

NDC(s):

72000-0120-06,

Primary Type:

Anti-Infective

Route of Administration:

Intravenous

About:

XENLETA is a Anti-Infective drug manufactured by Nabriva Therapeutics Us, Inc and administered via the Intravenous route of administration. The J Code: J0691 is aligned to the drug XENLETA.